|
⚲
|
| Keyboard |
| Nextbio Capital Management LP
✚
|
|
|---|---|
| CRD # | 332920 |
| SEC # | 801-136876 |
| CIK # | 0002038158 |
| AUM | 305.2 M (2026-06-26) |
| Employees | 6 (67% Investors, 0% Brokers) |
| Phone | 650-501-0882 |
| Address | 500 W 2nd Street Austin, TX 78701 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| CIK | Period |
|---|---|
| 0002038158 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Protagonist Therapeutics Inc | 24.2 | ||
| Shattuck Labs Inc | 20.3 | ||
| Vor Biopharma Inc | 17.8 | ||
| Compass Pathways PLC | 11.2 | ||
| Rhythm Pharmaceuticals Inc | 11.0 | ||
| Xenon Pharmaceuticals Inc | 10.7 | ||
| Marika Inc | 10.3 | ||
| Zenas Biopharma Inc | 8.3 | ||
| Inventiva Sa | 7.4 | ||
| Verastem Inc | 6.9 | ||
| Glycomimetics Inc | 6.8 | ||
| Oric Pharmaceuticals Inc | 6.6 | ||
| Structure Therapeutics Inc | 6.4 | ||
| Vaxcyte Inc | 5.5 | ||
| UNUM Therapeutics Inc | 5.0 | ||
| Olivia Ventures Inc | 4.5 | ||
| Evommune Inc | 4.2 | ||
| Oculis Holding AG | 4.0 | ||
| Zai Lab Ltd | 3.4 | ||
| FS Development Corp | 3.4 | ||
| Summit Therapeutics PLC | 1.7 | ||
| Restorbio Inc | 1.1 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| Other | Nexurabio SPV LLC | 2026-06-26 | 0.4 M | |
| Other | Nextbio Special Opportunities Fund LP | [2026-06-24] | 24.4 M | 24.4 M |
| Filed 2026-06-24 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose | ||||
| Other | Nextbio Evergreen LLC | [2026-03-23] | 90.8 M | |
| Filed 2025-08-01 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| Other | Nextbio Innovation SPV I LLC | [2026-03-23] | 2.6 M | |
| Filed 2025-05-07 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| Other | Nextbio Opportunity Adapt LLC | 2025-03-24 | 2.9 M | |
| HF | Nextbio Master Fund LP | [2024-08-29] | 1.9 M | 184.1 M |
| Filed 2025-07-11 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 8 | 305.2 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 8 | 305.2 |
| By Discretionary | ||
| Discretionary | 8 | 305.2 |
| Non-Discretionary | 0 | 0.0 |
| Total | 8 | 305.2 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 305.2 | |
| Total | 8 | 305.2 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Wade Kenny | Director | 86 | 31 | |
| Julie Hughes | Director | 43 | 18 | |
| Nextbio Capital Management LP | Executive Officer | 4 | 2 | |
| Nextbio Capital Evergreen GP LLC | Executive Officer | 1 | 1 | |
| Ky Phan | Director | 1 | 1 | |
| Nextbio Capital Special Opportunities Fund GP LLC | Executive Officer | 1 | 1 | |
| Nextbio Capital Management LP | Executive Officer | 1 | 1 | |
| Nextbio Capital Innovation SPV I GP LLC | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0002038158] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 25490013H51JWRLB8S49 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Prospect Capital Advisors LLC
✚
|
CA | 309.4 M |
|
S Squared Technology LLC
✚
|
308.0 M | |
|
DOMA Perpetual Capital Management LLC
✚
|
FL | 307.6 M |
|
Eastbay Asset Management LLC
✚
|
307.4 M | |
|
Marnell Management LLC
✚
|
MI | 306.1 M |
|
KBIT Management Ltd
✚
|
306.1 M | |
|
Mountaineer Partners Management LLC
✚
|
NY | 305.7 M |
|
Mission Value Partners LLC
✚
|
TN | 303.2 M |
|
Praxis Capital Management LLC
✚
|
IL | 301.4 M |
|
Parsow Management LLC
✚
|
301.2 M |